1hon MSN
7-year heart trial finds Lp(a) drug doesn’t prevent heart attacks, but testing still matters
A Cleveland Clinic-led trial found the drug pelacarsen cut Lp(a) by nearly 80% but did not prevent heart attacks or strokes.
An expert told Newsweek that carrying an inherited genetic change linked to cancer does not equal developing cancer.
A retrospective cohort of 91 adults with Alport syndrome or thin basement membrane nephropathy found that genetic test ...
A new mouse study that set out to test how sleep helps stabilize new memories has identified cells that may offer a genetic ...
Topline three-month data from Cohort 2 expected in the first quarter of 2027, with potential pivotal Phase 3 trial dosing anticipated in the second half of 2027 ...
In the 7-year, phase III, multicenter, international Lp(a) HORIZON trial, the novel medication pelacarsen lowered Lp(a) ...
In a prospective observational case-control study conducted at Tanta University Hospitals in Egypt, researchers identified ...
Researchers in China found a newly identified tick-borne virus in 10. 4 percent of 3,163 patients they tested.
HONG KONG SAR – Media OutReach Newswire – 7 November 2026 – Prof. Nancy IP, President and The Morningside Professor of ...
GeneDx partners with Mirum to offer free exome testing for rare diseases, funded entirely by the drugmaker, not insurers.
By every measure, the drugs were no better than placebos, full data revealed on Saturday. Was it the fault of the design of ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results